ECSP055895A - PHARMACEUTICAL ALLERGEN PRODUCT - Google Patents
PHARMACEUTICAL ALLERGEN PRODUCTInfo
- Publication number
- ECSP055895A ECSP055895A EC2005005895A ECSP055895A ECSP055895A EC SP055895 A ECSP055895 A EC SP055895A EC 2005005895 A EC2005005895 A EC 2005005895A EC SP055895 A ECSP055895 A EC SP055895A EC SP055895 A ECSP055895 A EC SP055895A
- Authority
- EC
- Ecuador
- Prior art keywords
- dosage forms
- allergen
- allergen product
- pharmaceutical
- rapid dispersion
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W90/00—Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
- Y02W90/10—Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La invención proporciona productos farmacéuticos que contienen alérgeno y en particular formas sólidas de dosis de alérgeno, de dispersión rápida. En particular, se proporcionan formas sólidas de dosis, no comprimidas, de dispersión rápida, adecuadas para la administración oromucosa, que comprende una matriz y al menos un alérgeno. Las matrices adecuadas son gelatina, almidón y manitol. También se proporcionan métodos para las formas de dosis.The invention provides pharmaceutical products containing allergen and in particular solid dosage forms of allergen, rapid dispersion. In particular, solid, non-compressed, rapid dispersion dosage forms suitable for oromucosal administration are provided, comprising a matrix and at least one allergen. Suitable matrices are gelatin, starch and mannitol. Methods for dosage forms are also provided.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200201825 | 2002-11-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP055895A true ECSP055895A (en) | 2006-09-18 |
Family
ID=35964203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2005005895A ECSP055895A (en) | 2002-11-26 | 2005-06-24 | PHARMACEUTICAL ALLERGEN PRODUCT |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN1731979B (en) |
EC (1) | ECSP055895A (en) |
UA (1) | UA93479C2 (en) |
ZA (1) | ZA200505111B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008152067A1 (en) * | 2007-06-12 | 2008-12-18 | Alk-Abelló A/S | An allergen dosage form comprising an antihistamine |
JP5800527B2 (en) * | 2010-03-30 | 2015-10-28 | 日東電工株式会社 | Stabilized pharmaceutical composition, stabilized pharmaceutical composition solution preparation, film-form preparation and method for producing film-form preparation |
CN103675271B (en) * | 2013-12-23 | 2016-01-06 | 北京新华联协和药业有限责任公司 | Anaphylactia allergen colloidal gold diagnosis test strips and preparation method thereof |
CN114053402A (en) * | 2020-08-03 | 2022-02-18 | 格林生物医药科技(天津)有限公司 | Allergen preparation |
CN114588130B (en) * | 2020-11-20 | 2023-07-04 | 四川好医生攀西药业有限责任公司 | Adhesive bandage containing periplaneta americana active ingredient and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9901819D0 (en) * | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
GB9908014D0 (en) * | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
-
2003
- 2003-11-14 UA UAA200506275A patent/UA93479C2/en unknown
- 2003-11-26 CN CN2003801078658A patent/CN1731979B/en not_active Expired - Fee Related
-
2005
- 2005-06-23 ZA ZA200505111A patent/ZA200505111B/en unknown
- 2005-06-24 EC EC2005005895A patent/ECSP055895A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1731979A (en) | 2006-02-08 |
ZA200505111B (en) | 2006-12-27 |
UA93479C2 (en) | 2011-02-25 |
CN1731979B (en) | 2010-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05005528A (en) | Pharmaceutical allergen product. | |
CO5700707A2 (en) | PHARMACEUTICAL PRODUCTS | |
ES2171268T3 (en) | FORMULATIONS OF TRAMADOL OF MULTIPLE UNITS. | |
AR033423A1 (en) | PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES | |
HK1067544A1 (en) | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms | |
DE60330322D1 (en) | MEDICINES microparticles | |
IL131651A0 (en) | A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same | |
AR024966A1 (en) | PHARMACEUTICAL FORMULATION | |
ES2145774T3 (en) | ADENOSINE DERIVATIVES THAT HAVE AGONIST ACTIVITY IN A2. | |
PA8575701A1 (en) | ACID INSULIN PREPARATIONS WITH IMPROVED STABILITY | |
CY1105231T1 (en) | SUSTAINED RELEASE ORAL DOSAGE COMPOSITION | |
AR026610A1 (en) | A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
UY26372A1 (en) | "IMIDAZO-3-IL-AMINAS BICÍCLICAS PROCEDURE FOR ITS PREPARATION AND DRUGS THAT CONTAIN THEM" | |
AR071828A1 (en) | TOBACCO PRODUCT FOR ORAL USE | |
ECSP055895A (en) | PHARMACEUTICAL ALLERGEN PRODUCT | |
ECSP066553A (en) | MASTICABLE ADMINISTRATION FORMS, NOT INDIVIDUALLY DOSED COMPRESSED. | |
HRP20080178T3 (en) | Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances | |
DE60102590D1 (en) | PHARMACEUTICAL FORMS FOR TREATING ORAL MYCOSIS | |
WO2004075875A8 (en) | Dosage form having a saccharide matrix | |
MXPA03008420A (en) | Solid orally-dispersible pharmaceutical formulation. | |
AR066455A2 (en) | USE OF N-METHYL-N COMPOUNDS - [(1R) -1-PHENYL-2- (3R) -3-HYDROXIPIRROLIDIN -1-IL - = - ETIL] -2,2-DIFENYL ACETAMIDE TO PRODUCE A MEDICINAL PRODUCT FOR THE TREATMENT OF INTESTINAL NON-INFLAMMATORY DISEASES | |
AR042677A1 (en) | ORAL CARE COMPOSITIONS AND METHODS | |
DE50105771D1 (en) | IBUPROFEN-ACTIVE PREPARATION | |
AR025060A1 (en) | PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPILMETILCELLULOSE CAPSULES | |
AR031649A1 (en) | DRONEDARONA PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION |